Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2022-2025
Title: Gonçalo Bernardes: Innovator in TRPV2 Antagonists
Introduction
Gonçalo Bernardes is a notable inventor based in Lisbon, Portugal. He has made significant contributions to the field of molecular medicine, particularly through his research on TRPV2 antagonists. His work focuses on the therapeutic potential of Piperlongumine compounds.
Latest Patents
Gonçalo Bernardes holds a patent related to TRPV2 antagonists. This invention pertains to the discovery that Piperlongumine compounds, including Piperlongumine and its analogues, derivatives, and prodrugs, act as reversible, allosteric antagonists of the transient receptor potential vanilloid 2 channel (TRPV2). The patent outlines methods for treating conditions characterized by TRPV2 expression using these compounds.
Career Highlights
Throughout his career, Gonçalo Bernardes has been associated with prestigious institutions such as the Gulbenkian Institute for Molecular Medicine. His research has contributed to advancements in understanding the role of TRPV2 in various medical conditions.
Collaborations
Gonçalo has collaborated with notable colleagues, including Tiago Rodrigues and João Conde. Their joint efforts have furthered research in the field of molecular medicine.
Conclusion
Gonçalo Bernardes is a prominent figure in the realm of molecular medicine, with a focus on TRPV2 antagonists and their therapeutic applications. His innovative work continues to impact the field significantly.